0001878646-22-000021.txt : 20220609 0001878646-22-000021.hdr.sgml : 20220609 20220609102251 ACCESSION NUMBER: 0001878646-22-000021 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220609 DATE AS OF CHANGE: 20220609 EFFECTIVENESS DATE: 20220609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Code Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001852269 IRS NUMBER: 851834089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-448615 FILM NUMBER: 221005165 BUSINESS ADDRESS: STREET 1: 2801 STERLING DRIVE CITY: HATFIELD STATE: PA ZIP: 19440 BUSINESS PHONE: 215-996-3006 MAIL ADDRESS: STREET 1: 2801 STERLING DRIVE CITY: HATFIELD STATE: PA ZIP: 19440 D 1 primary_doc.xml X0708 D LIVE 0001852269 Code Biotherapeutics, Inc. 2801 STERLING DRIVE HATFIELD PA PENNSYLVANIA 19440 215-996-3006 DELAWARE None None Corporation true 2020 Brian McVeigh c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Executive Officer Director Russ Fein c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Executive Officer Director Kathy Rouan c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Director Joseph Truitt c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Director Dmitry Kuzmin c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Director Robert Lin c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Director Victor Stone c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Director Edward Mathers c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Director Robert C Getts c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Executive Officer Lauren Kaskiel c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Executive Officer Erin Brubaker c/o Issuer 2801 Sterling Drive Hatfield PA PENNSYLVANIA 19440 Executive Officer Other Health Care Decline to Disclose 06b false 2022-05-25 false true false 0 74999971 37499995 37499976 false 10 0 0 0 false Code Biotherapeutics, Inc. /s/Brian P. McVeigh Brian P. McVeigh Chief Executive Officer 2022-06-09